ClinicalTrials.Veeva

Menu

Health Literacy Project

Duke University logo

Duke University

Status

Begins enrollment this month

Conditions

Epilepsy

Treatments

Behavioral: Health Literacy Educational Session
Other: Health Literacy Educational Session- Comparator

Study type

Interventional

Funder types

Other

Identifiers

NCT06634901
PRO00116250

Details and patient eligibility

About

Evaluating changes in knowledge, attitude, and practices (KAP) related to epilepsy and its treatment as a result of an educational intervention among adolescents with epilepsy to determine if improved KAP about epilepsy results in improved medication adherence and less perceived stigma.

Full description

This proof-of-concept study aims to evaluate the impact of a targeted health literacy intervention on knowledge and attitudes about epilepsy and its treatment, and reported medication adherence and stigma among adolescents with epilepsy in Uganda.

Research Questions:

  1. What is the impact of a culturally relevant information session on the knowledge of epilepsy and its treatment among adolescents with epilepsy in Uganda?
  2. What is the impact of such an educational session on reported medication adherence and reported stigma among this group?

The investigators hypothesize that a culturally relevant educational intervention will significantly improve knowledge about epilepsy and its treatment, increase medication adherence, and reduce stigma among adolescents with epilepsy in Uganda. This hypothesis is based on the premise that tailored health literacy interventions can address specific misconceptions and barriers to care, thereby improving health outcomes for PWE (persons with epilepsy) in contexts burdened by significant treatment gaps and cultural stigmatization.

Enrollment

60 estimated patients

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adolescents with a diagnosis of epilepsy attending a clinic at one of the study sites.
  • Ages 12-18 years
  • Ability and willingness to provide informed assent and guardian consent to participate in the study.
  • English, Runyankole or Luganda language proficiency.

Exclusion criteria

  • Unable or unwilling to provide informed consent or assent to participate in the study.
  • Developmental/cognitive challenges that hinder participation in the intervention or completion of surveys.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Health Literacy Educational Session- Control Group Testing
Active Comparator group
Description:
Participants will receive pre- and post-testing at the same interval as the experimental arm. Rather than receiving the educational session intervention, participants will have lunch during the interval. The comparator group will receive the intervention after all primary and secondary outcome measures have been completed.
Treatment:
Other: Health Literacy Educational Session- Comparator
Behavioral: Health Literacy Educational Session
Health Literacy Educational Session- Experimental Group Testing
Experimental group
Description:
Participants are divided into groups of 6-10 adolescents each to receive the educational session intervention, with those aged 12-15 in different groups from those aged 16-18 due to potential differences in question focus.
Treatment:
Behavioral: Health Literacy Educational Session

Trial contacts and locations

2

Loading...

Central trial contact

Deborah Koltai, MD; Paula Njeru, MsCGH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems